These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2170064)

  • 1. Serum immunoreactive prolyl 4-hydroxylase as a specific marker of hepatocellular necrosis.
    Nagai Y; Toda G
    Clin Chim Acta; 1990 Sep; 190(1-2):109-10. PubMed ID: 2170064
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on serum immunoreactive prolyl 4-hydroxylase in liver diseases--its elevation both in hepatocellular damage and cholestatic diseases.
    Nagai Y; Yoshiba M
    Clin Chim Acta; 1988 Jun; 175(1):27-36. PubMed ID: 2844441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are serum type III procollagen and prolyl hydroxylase useful as noninvasive markers of liver disease in patients with cystic fibrosis?
    Leonardi S; Giambusso F; Sciuto C; Castiglione S; Castiglione N; La Rosa M
    J Pediatr Gastroenterol Nutr; 1998 Nov; 27(5):603-5. PubMed ID: 9822332
    [No Abstract]   [Full Text] [Related]  

  • 4. Selectivity of serum immunoreactive prolyl 4-hydroxylase as a marker for hepatic necrosis.
    Nagai Y; Kato M; Toda G
    J Gastroenterol Hepatol; 1992; 7(3):253-6. PubMed ID: 1319223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical significance of serum prolyl hydroxylase in diabetic microangiopathy].
    Shioi A; Nishizawa Y; Morii H
    Nihon Rinsho; 1998 Jan; 56 Suppl 3():126-8. PubMed ID: 9513402
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum immunoreactive prolyl hydroxylase in liver disease.
    Tuderman L; Risteli J; Miettinen TA; Kivirikko KI
    Eur J Clin Invest; 1977 Dec; 7(6):537-41. PubMed ID: 204493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Serum prolyl hydroxylase values in liver diseases].
    Miyabayashi C; Inoue K; Takahara T; Matsui S; Kojima T; Sasaki H; Ooshima A; Iwata K; Yoshida S
    Nihon Shokakibyo Gakkai Zasshi; 1986 Oct; 83(10):2181-9. PubMed ID: 3029473
    [No Abstract]   [Full Text] [Related]  

  • 8. Human prolyl-hydroxylase: only a marker of hepatic damage?
    Tamaro G; Pozzato G; Moretti M
    Int J Clin Lab Res; 1993; 23(4):228. PubMed ID: 8123880
    [No Abstract]   [Full Text] [Related]  

  • 9. Human prolyl hydroxylase. Purification, radioimmunoassay and clinical studies in liver diseases.
    Nagai Y; Oka H
    Gastroenterol Jpn; 1985 Feb; 20(1):53-64. PubMed ID: 2991066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of hepatic injury on prolyl 3-hydroxylase and 4-hydroxylase activities in rat liver and on immunoreactive prolyl 4-hydroxylase concentrations in the liver and serum.
    Risteli J; Tuderman L; Tryggvason K; Kivirikko KI
    Biochem J; 1978 Jan; 170(1):129-35. PubMed ID: 204299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prolyl hydroxylase].
    Yamada S; Kawasaki H
    Nihon Rinsho; 1995 Feb; 53 Su Pt 1():383-5. PubMed ID: 8753452
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum lysyl oxidase activity in chronic liver disease in comparison with serum levels of prolyl hydroxylase and laminin.
    Murawaki Y; Kusakabe Y; Hirayama C
    Hepatology; 1991 Dec; 14(6):1167-73. PubMed ID: 1683640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical significance of the determination of serum immunoreactive prolyl hydroxylase (SIRPH) in hepatic fibrosis].
    Suzuki H; Suzuki M; Okabe K; Uchikoshi T
    Nihon Shokakibyo Gakkai Zasshi; 1987 Jun; 84(6):1265-71. PubMed ID: 2822984
    [No Abstract]   [Full Text] [Related]  

  • 14. A sandwich immunoassay for human prolyl 4-hydroxylase using monoclonal antibody.
    Yoshida S; Bai Y; Muragaki Y; Ooshima A; Inada K; Nagai Y; Obata K; Iwata K; Hashida S; Ishikawa E
    Clin Chim Acta; 1986 Oct; 160(1):37-46. PubMed ID: 3021363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Significance of prolyl hydroxylase analysis in clinical tests].
    Yamada S; Kawasaki H
    Nihon Rinsho; 1989 Dec; 48 Suppl():321-3. PubMed ID: 2560079
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunoreactive prolyl hydroxylase protein and galactosylhydroxylysyl glucosyltransferase activity in breast tissues and sera of patients with primary breast cancer.
    Bolarin DM
    Res Commun Chem Pathol Pharmacol; 1983 Mar; 39(3):493-502. PubMed ID: 6304825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum prolyl hydroxylase protein in experimental liver cancer.
    Bolarin DM
    Acta Physiol Hung; 1988; 71(1):55-9. PubMed ID: 2839006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is serum prolyl 4-hydroxylase useful as noninvasive marker of liver fibrosis in patients with biliary atresia?
    Kobayashi H; Tamura T; Yamataka A; Lane GJ; Miyano T
    J Pediatr Surg; 2005 Aug; 40(8):1366-7. PubMed ID: 16080952
    [No Abstract]   [Full Text] [Related]  

  • 19. [Serum and tissue prolyl hydroxylase (PH) in hepatocellular carcinoma and gastrointestinal cancer].
    Suzuki M; Suzuki H; Kato Y; Okabe K; Uchikoshi T; Okazaki N
    Nihon Shokakibyo Gakkai Zasshi; 1988 Oct; 85(10):2232-8. PubMed ID: 2850377
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical significance of serum prolyl hydroxylase beta-subunit levels determined using monoclonal antibody].
    Yasuhara M; Matsuda Y; Takada A
    Nihon Shokakibyo Gakkai Zasshi; 1987 Jun; 84(6):1225-32. PubMed ID: 2822982
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.